Thyroid-associated ophthalmopathy (TAO) is the leading orbital disorder linked to autoimmune thyroid diseases, impacting vision and quality of life. Current clinical assessments suffer from subjectivity, complicating personalized care. Recent advances in imaging—including ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) —offer detailed visualization of orbital anatomy and pathological changes. While ultrasound assesses blood flow dynamics, CT excels in quantifying extraocular muscle and fat volumes, aiding surgical planning and disease staging.
MRI provides superior soft tissue resolution and multiparametric insights, facilitating precise diagnosis, activity evaluation, and treatment monitoring. Integrating these modalities enhances clinical decision-making and treatment effectiveness in TAO. To read more, click here . ##Reference## Xu Z, Xue Z, Lyu Z.…
